ARTICLE | Company News
NephroGenex renal news
March 14, 2016 7:00 AM UTC
NephroGenex halted clinical development of oral Pyridorin pyridoxamine to treat diabetic nephropathy in light of the remaining trial costs, the company’s cash balance and market conditions. NephroGen...